{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T12:32:33Z","timestamp":1773405153655,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100019446","name":"Medical and Health Science and Technology Development Project of Shandong Province","doi-asserted-by":"publisher","award":["202206030328"],"award-info":[{"award-number":["202206030328"]}],"id":[{"id":"10.13039\/501100019446","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","journalofsurgicalresearch.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Surgical Research"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.jss.2024.12.013","type":"journal-article","created":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T10:48:25Z","timestamp":1736765305000},"page":"249-256","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Sildenafil Attenuates Persistent Pulmonary Hypertension of the Newborn via Inhibiting the Growth and Migration of Pulmonary Artery Smooth Muscle Cells"],"prefix":"10.1016","volume":"306","author":[{"given":"Lili","family":"Kang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujie","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianghong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XiaoMei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zilong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2013-7624","authenticated-orcid":false,"given":"Xiaoying","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jss.2024.12.013_bib1","doi-asserted-by":"crossref","first-page":"L299","DOI":"10.1152\/ajplung.00271.2013","article-title":"Peroxisome proliferator activated receptor-gamma-Rho-kinase interactions contribute to vascular remodeling after chronic intrauterine pulmonary hypertension","volume":"306","author":"Gien","year":"2014","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.jss.2024.12.013_bib2","doi-asserted-by":"crossref","first-page":"L755","DOI":"10.1152\/ajplung.00138.2010","article-title":"Cinaciguat, a soluble guanylate cyclase activator, augments cGMP after oxidative stress and causes pulmonary vasodilation in neonatal pulmonary hypertension","volume":"301","author":"Chester","year":"2011","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.jss.2024.12.013_bib3","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.resp.2010.08.018","article-title":"Mitochondrial oxidant stress increases PDE5 activity in persistent pulmonary hypertension of the newborn","volume":"174","author":"Farrow","year":"2010","journal-title":"Respir Physiol Neurobiol"},{"key":"10.1016\/j.jss.2024.12.013_bib4","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3389\/fphar.2015.00047","article-title":"Hypoxia inducible factor signaling and experimental persistent pulmonary hypertension of the newborn","volume":"6","author":"Wedgwood","year":"2015","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jss.2024.12.013_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173618","article-title":"Down-regulation of lncRNA Gas5 promotes hypoxia-induced pulmonary arterial smooth muscle cell proliferation by regulating KCNK3 expression","volume":"889","author":"Hao","year":"2020","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jss.2024.12.013_bib6","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s12872-017-0569-3","article-title":"Efficacy and safety of oral sildenafil in children with Down syndrome and pulmonary hypertension","volume":"17","author":"Beghetti","year":"2017","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.jss.2024.12.013_bib7","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.2174\/1381612811209023034","article-title":"The use of sildenafil in the treatment of persistent pulmonary hypertension of the newborn: a review of the literature","volume":"18","author":"Iacovidou","year":"2012","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.jss.2024.12.013_bib8","doi-asserted-by":"crossref","first-page":"171","DOI":"10.4103\/2249-4847.105958","article-title":"Is sildenafil an effective therapy in the management of persistent pulmonary hypertension?","volume":"1","author":"Yaseen","year":"2012","journal-title":"J Clin Neonatol"},{"key":"10.1016\/j.jss.2024.12.013_bib17","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/FJC.0000000000001373","article-title":"Sildenafil improves pulmonary vascular remodeling in a rat model of persistent pulmonary hypertension of the newborn","volume":"81","author":"Kang","year":"2023","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.jss.2024.12.013_bib18","doi-asserted-by":"crossref","first-page":"14549","DOI":"10.1111\/jcmm.16083","article-title":"Farnesoid X receptor activation induces antitumour activity in colorectal cancer by suppressing JAK2\/STAT3 signalling via transactivation of SOCS3 gene","volume":"24","author":"Li","year":"2020","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.jss.2024.12.013_bib19","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.yexcr.2018.01.015","article-title":"Inhibition of miR-361-5p suppressed pulmonary artery smooth muscle cell survival and migration by targeting ABCA1 and inhibiting the JAK2\/STAT3 pathway","volume":"363","author":"Zhang","year":"2018","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.jss.2024.12.013_bib20","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12742","article-title":"Blockade of JAK2 protects mice against hypoxia-induced pulmonary arterial hypertension by repressing pulmonary arterial smooth muscle cell proliferation","volume":"53","author":"Zhang","year":"2020","journal-title":"Cell Prolif"},{"key":"10.1016\/j.jss.2024.12.013_bib21","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1165\/rcmb.2019-0431OC","article-title":"Targeting jak-stat signaling in experimental pulmonary hypertension","volume":"64","author":"Yerabolu","year":"2021","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.jss.2024.12.013_bib16","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1080\/13880209.2021.1917629","article-title":"Xinmai 'an extract enhances the efficacy of sildenafil in the treatment of pulmonary arterial hypertension via inhibiting MAPK signalling pathway","volume":"59","author":"Zhu","year":"2021","journal-title":"Pharm Biol"},{"key":"10.1016\/j.jss.2024.12.013_bib22","doi-asserted-by":"crossref","first-page":"595","DOI":"10.3892\/ijmm.2020.4813","article-title":"Astragaloside IV blocks monocrotalineinduced pulmonary arterial hypertension by improving inflammation and pulmonary artery remodeling","volume":"47","author":"Jin","year":"2021","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.jss.2024.12.013_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.111056","article-title":"Protective effects of dioscin on vascular remodeling in pulmonary arterial hypertension via adjusting GRB2\/ERK\/PI3K-AKT signal","volume":"133","author":"Yang","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jss.2024.12.013_bib24","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1080\/17512433.2020.1850257","article-title":"Oral drugs used to treat persistent pulmonary hypertension of the newborn","volume":"13","author":"Zhang","year":"2020","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.jss.2024.12.013_bib25","doi-asserted-by":"crossref","first-page":"L577","DOI":"10.1152\/ajplung.00449.2003","article-title":"Sildenafil alters calcium signaling and vascular tone in pulmonary arteries from chronically hypoxic rats","volume":"287","author":"Pauvert","year":"2004","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"2 Pt 2","key":"10.1016\/j.jss.2024.12.013_bib26","first-page":"H487","article-title":"Selective inhibition of cGMP-inhibitable cAMP phosphodiesterase decreases pulmonary vasoreactivity","volume":"261","author":"Haynes","year":"1991","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jss.2024.12.013_bib27","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2147\/DDDT.S6208","article-title":"Update on the clinical utility of sildenafil in the treatment of pulmonary arterial hypertension","volume":"4","author":"Ramani","year":"2010","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.jss.2024.12.013_bib28","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1186\/s12887-019-1801-3","article-title":"Use of sildenafil in an infant with persistent pulmonary hypertension secondary to lung and renal hypoplasia - a case report","volume":"19","author":"Lavie-Nevo","year":"2019","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.jss.2024.12.013_bib29","first-page":"73","article-title":"Persistent pulmonary hypertension in the newborn: therapeutic effect of sildenafil","volume":"51","author":"Cruz-Blanquel","year":"2008","journal-title":"Proc West Pharmacol Soc"},{"key":"10.1016\/j.jss.2024.12.013_bib30","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1055\/s-0029-1239496","article-title":"The use of sildenafil in persistent pulmonary hypertension of the newborn","volume":"27","author":"Vargas-Origel","year":"2010","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.jss.2024.12.013_bib31","article-title":"Sildenafil for pulmonary hypertension in neonates","volume":"8","author":"Kelly","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jss.2024.12.013_bib32","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1164\/ajrccm.165.8.2107097","article-title":"Intravenous sildenafil lowers pulmonary vascular resistance in a model of neonatal pulmonary hypertension","volume":"165","author":"Shekerdemian","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jss.2024.12.013_bib33","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1097\/00003246-200105000-00024","article-title":"Nebulized sildenafil is a selective pulmonary vasodilator in lambs with acute pulmonary hypertension","volume":"29","author":"Ichinose","year":"2001","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jss.2024.12.013_bib34","doi-asserted-by":"crossref","first-page":"4462","DOI":"10.1111\/bph.14807","article-title":"Effects of the FGF receptor-1 inhibitor, infigratinib, with or without sildenafil, in experimental pulmonary arterial hypertension","volume":"176","author":"Felix","year":"2019","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jss.2024.12.013_bib35","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.phrs.2009.01.007","article-title":"Inhibition of cGMP phosphodiesterase 5 suppresses serotonin signalling in pulmonary artery smooth muscles cells","volume":"59","author":"Li","year":"2009","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jss.2024.12.013_bib36","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1161\/ATVBAHA.112.300121","article-title":"Sildenafil potentiates bone\u00a0morphogenetic protein signaling in pulmonary arterial smooth muscle cells and in experimental pulmonary hypertension","volume":"33","author":"Yang","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jss.2024.12.013_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.755077","article-title":"Magnolol attenuates right ventricular hypertrophy and fibrosis in hypoxia-induced pulmonary arterial hypertensive rats through inhibition of the JAK2\/STAT3 signaling pathway","volume":"12","author":"Fu","year":"2021","journal-title":"Front Pharmacol"}],"container-title":["Journal of Surgical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480424008060?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480424008060?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T20:58:12Z","timestamp":1741985892000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022480424008060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":30,"alternative-id":["S0022480424008060"],"URL":"https:\/\/doi.org\/10.1016\/j.jss.2024.12.013","relation":{},"ISSN":["0022-4804"],"issn-type":[{"value":"0022-4804","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sildenafil Attenuates Persistent Pulmonary Hypertension of the Newborn via Inhibiting the Growth and Migration of Pulmonary Artery Smooth Muscle Cells","name":"articletitle","label":"Article Title"},{"value":"Journal of Surgical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jss.2024.12.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}